Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Engaging with Regulators for Single-Arm Oncology Research Trials
When well-planned and well-executed, single-arm trials can accelerate access to life-saving therapies that might otherwise never reach desperate cancer patients. read more
Horizon Lines: A Quarterly Review of NDAs – October- December 2025
This quarterly review of New Drug Applications contains data for applications approved for the first time during the last quarter of 2025, which includes New Molecular Entities (NMEs) and new biologics. A total of 40 applications were approved by the FDA during these three months. read more
How AI is Transforming Clinical Trials
AI is already reshaping the clinical trials industry and that transformation looks set to continue over the next five years. New technologies will enable the development of more personalized medicines, empower more responsive trial designs and improve informed decision making by unlocking new data insights. read more
From Service Provider to Strategic Partner
As drug development grows more complex and timelines compress, sponsors require CDMO relationships built on integration, flexibility, and shared accountability read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Cellipont Bioservices Announces Release of 100th GMP Batch
Thursday, July 30, 2026
Cellipont Bioservices announced the successful release of its 100th GMP batch at its manufacturing facility in The Woodlands, Texas. read more
Piramal Pharma Starts FY27 With 17% Revenue Growth, Higher EBITDA
Thursday, July 30, 2026
Piramal Pharma said it began FY27 with stronger revenue and margin expansion, driven by broad-based growth across its contract development and ... read more
Harbour BioMed, Sinopharm Form R&D Consortium for Innovative Biologics
Wednesday, July 29, 2026
Harbour BioMed and China National Pharmaceutical Group announced a strategic collaboration to establish a joint innovation R&D consortium focused on ... read more
AsymBio Breaks Ground on Fengxian R&D Building to Expand Biologics Services
Wednesday, July 29, 2026
AsymBio has begun construction of a new R&D building at its Shanghai Fengxian site, a move the company said will strengthen its biologics CDMO ... read more
ICON, Anthropic Launch Multi-Year AI Collaboration for Clinical Trials
Tuesday, July 28, 2026
ICON has announced a multi-year collaboration with Anthropic to bring Claude’s AI capabilities across the clinical trial lifecycle, expanding the ... read more